The story of Viagra, and its parent company copyright, presents a complex case study for investors. Originally a blockbuster drug, generating billions in income, its patent expiration created a flood of lower-priced alternatives , significantly impacting its dominance. While specific firms may try to capitalize on male sexual dysfunction, the prese